Downregulation of MicroRNA-222 Reduces Insulin Resistance in Rats with PCOS by Inhibiting Activation of the MAPK/ERK Pathway via Pten.

Ye H, Liu XJ, Hui Y, Liang YH, Li CH, Wan Q

Open source

DOI
10.1016/j.omtn.2020.07.014
Published
2020 Dec 4
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2020.07.014,
  title = {Downregulation of MicroRNA-222 Reduces Insulin Resistance in Rats with PCOS by Inhibiting Activation of the MAPK/ERK Pathway via Pten.},
  author = {Ye H and Liu XJ and Hui Y and Liang YH and Li CH and Wan Q},
  year = {2020},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2020.07.014},
  url = {https://doi.org/10.1016/j.omtn.2020.07.014}
}

RIS

TY  - JOUR
TI  - Downregulation of MicroRNA-222 Reduces Insulin Resistance in Rats with PCOS by Inhibiting Activation of the MAPK/ERK Pathway via Pten.
AU  - Ye H
AU  - Liu XJ
AU  - Hui Y
AU  - Liang YH
AU  - Li CH
AU  - Wan Q
PY  - 2020
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2020.07.014
UR  - https://doi.org/10.1016/j.omtn.2020.07.014
ER  - 

APA

H, Y., XJ, L., Y, H., YH, L., CH, L., & Q, W. (2020). Downregulation of MicroRNA-222 Reduces Insulin Resistance in Rats with PCOS by Inhibiting Activation of the MAPK/ERK Pathway via Pten.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2020.07.014

Source records